Communiqué de presse
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
May 18, 2020 After two doses all participants evaluated to date across the 25 µg and 100 µg dose […]
Vous n'êtes pas encore inscrit ?
InscriptionMay 18, 2020 After two doses all participants evaluated to date across the 25 µg and 100 µg dose […]